Industries are continuously evolving, and the pharma industry is no exception. There are trends impacting the way we think about pharma, how pharma development is conducted, and opportunities for the pharma industry to make an impact on a societal level.
Within pharma, executives constantly make difficult strategic decisions pertaining to the company’s assets and those decisions can be worth billions of dollars. In today’s environment, rapid decision-making is imperative as time translates not only to sales, but to patient outcomes. At the same time, drug development margins have been declining, forcing the industry to reinvent itself.